Cargando…

Non-Alcoholic Fatty Liver in Patients with Chylomicronemia

Non-alcoholic fatty liver disease (NAFLD) is frequent in patients with features of the metabolic syndrome (MetS), obesity, or type 2 diabetes. Lipoprotein lipase (LPL) is the main driver of triglyceride (TG) hydrolysis in chylomicrons and very-low density lipoproteins (VLDL). In some patients with M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maltais, Mélanie, Brisson, Diane, Gaudet, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916177/ https://www.ncbi.nlm.nih.gov/pubmed/33572376 http://dx.doi.org/10.3390/jcm10040669

Ejemplares similares

Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia
por: Tremblay, Karine, et al.
Publicado: (2020)

Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndrome
por: Larouche, Miriam, et al.
Publicado: (2023)

The burden of familial chylomicronemia syndrome in Canadian patients
por: Gaudet, Daniel, et al.
Publicado: (2020)

Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients
por: Liu, Chao, et al.
Publicado: (2017)

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
por: Meyers, Charles Daniel, et al.
Publicado: (2015)

Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles
por: O’Dea, Louis St L, et al.
Publicado: (2019)

Current Diagnosis and Management of Primary Chylomicronemia
por: Okazaki, Hiroaki, et al.
Publicado: (2021)

A Comprehensive Update on the Chylomicronemia Syndrome
por: Goldberg, Ronald B., et al.
Publicado: (2020)

The Evolving Story of Multifactorial Chylomicronemia Syndrome
por: Paquette, Martine, et al.
Publicado: (2022)

Deletion of GPIHBP1 causing severe chylomicronemia
por: Rios, Jonathan J., et al.
Publicado: (2011)

Familial chylomicronemia syndrome: a case report
por: Susheela, Ammu Thampi, et al.
Publicado: (2021)

Two Case Reports of Familial Chylomicronemia Syndrome
por: Chen, Yan-Hui, et al.
Publicado: (2012)

Familial chylomicronemia syndrome: importance of diagnostic vigilance
por: Ueda, Masako
Publicado: (2022)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Delvin, Edgard, et al.
Publicado: (2015)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Pregnancy in Familial Chylomicronemia Syndrome: Plasmapheresis as Therapeutic Approach
por: Leskovar, Dunja, et al.
Publicado: (2021)

Familial chylomicronemia syndrome in children: a diagnosis challenge
por: Ariza, María José, et al.
Publicado: (2022)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Hypertriglyceridemia Induced Pancreatitis (Chylomicronemia Syndrome) Treated with Supportive Care
por: Uysal, Emin, et al.
Publicado: (2014)

Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis
por: Vidanapathirana, Dinesha Maduri, et al.
Publicado: (2017)

Chylomicronemia through a burr hole: A case report
por: Loh, Wann Jia, et al.
Publicado: (2022)

Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience
por: Williams, Kate, et al.
Publicado: (2023)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia
por: Chang, Ya-Hui, et al.
Publicado: (2022)

Development of a novel PRO instrument for use in familial chylomicronemia syndrome
por: Davidson, David, et al.
Publicado: (2021)

Familial Chylomicronemia Syndrome-Induced Acute Necrotizing Pancreatitis during Pregnancy
por: Coronado Arroyo, Julia Cristina, et al.
Publicado: (2021)

An interesting case of familial chylomicronemia syndrome in a cleft palate child
por: Adenwalla, H. S., et al.
Publicado: (2008)

Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome
por: Zhang, Yonghong, et al.
Publicado: (2016)

Association between salivary pH and metabolic syndrome in women: a cross-sectional study
por: Tremblay, Monique, et al.
Publicado: (2012)

Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality
por: Villeneuve, Sylvia, et al.
Publicado: (2015)

Association study between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and metabolic syndrome
por: Tremblay, Monique, et al.
Publicado: (2018)

Palmar Striated Xanthomas in Clinical Practice
por: Roy, Nathalie, et al.
Publicado: (2022)

Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease
por: Yamamoto, Kuniko, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Autophagy and Non-Alcoholic Fatty Liver Disease
por: Lavallard, Vanessa J., et al.
Publicado: (2014)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Plasma exchange therapy for familial chylomicronemia syndrome in infant: A case report
por: Han, Lei, et al.
Publicado: (2022)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ij71d6krjebvhmtdb57m08u8nv